Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies-Reference-Cited by-同舟云学术

Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies

Published:2018-07-13 Issue:6 Volume:182 Page:843-850
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Drevon Louis¹^ORCID,Marceau Alice²,Maarek Odile¹,Cuccuini Wendy¹,Clappier Emmanuelle¹,Eclache Virginie³,Cluzeau Thomas⁴,Richez Valentine⁴,Berkaoui Inès⁴,Dimicoli-Salazar Sophie⁵,Bidet Audrey⁵,Vial Jean-Philippe⁵,Park Sophie⁶,Vieira Dos Santos Christina⁶,Kaphan Eléonore⁶,Berthon Céline²,Stamatoullas Aspasia⁷,Delhommeau François⁸,Abermil Nassera⁸,Braun Thorsten³,Sapena Rosa⁹,Lusina Daniel³,Renneville Aline²,Adès Lionel¹,Raynaud Sophie⁴,Fenaux Pierre¹^ORCID

Affiliation:

1. Hôpital Saint-Louis; Assistance Publique Hôpitaux de Paris (APHP); University Paris Diderot (Paris 7); Paris France

2. Centre Hospitalier Régional Universitaire (CHRU) de Lille; Lille France

3. Hôpital Avicenne; APHP; University Paris 13; Bobigny France

4. Centre Hospitalier Universitaire (CHU) de Nice; Nice France

5. CHU de Bordeaux; Bordeaux France

6. CHU Grenoble Alpes; Grenoble France

7. CHU de Rouen; Rouen France

8. Hôpital Saint-Antoine; APHP; University Pierre et Marie Curie (Paris 6); Paris France

9. GFM (Groupe Francophone des Myélodysplasies); Hôpital Saint-Louis; Paris France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15490/fullpdf

Reference33 articles.

1. Myelodysplastic syndromes;Adès;The Lancet,2014

2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

3. Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance;Barraco;British Journal of Haematology,2017

4. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders;Ernst;Nature Genetics,2010

5. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q;Fenaux;Blood,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax;Clinical Cancer Research;2024-02-01

2. Myelodysplastic Syndrome;Comprehensive Hematology and Stem Cell Research;2024

3. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH);Current Research in Translational Medicine;2023-10

4. Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10

5. Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8;Cancers;2023-07-27